Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression
Kazuhiro Shiizaki, … , Masayuki Murata, Makoto Kuro-o
Kazuhiro Shiizaki, … , Masayuki Murata, Makoto Kuro-o
Published June 29, 2021
Citation Information: J Clin Invest. 2021;131(16):e145693. https://doi.org/10.1172/JCI145693.
View: Text | PDF
Research Article Nephrology

Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression

  • Text
  • PDF
Abstract

The Western pattern diet is rich not only in fat and calories but also in phosphate. The negative effects of excessive fat and calorie intake on health are widely known, but the potential harms of excessive phosphate intake are poorly recognized. Here, we show the mechanism by which dietary phosphate damages the kidney. When phosphate intake was excessive relative to the number of functioning nephrons, circulating levels of FGF23, a hormone that increases the excretion of phosphate per nephron, were increased to maintain phosphate homeostasis. FGF23 suppressed phosphate reabsorption in renal tubules and thus raised the phosphate concentration in the tubule fluid. Once it exceeded a threshold, microscopic particles containing calcium phosphate crystals appeared in the tubule lumen, which damaged tubule cells through binding to the TLR4 expressed on them. Persistent tubule damage induced interstitial fibrosis, reduced the number of nephrons, and further boosted FGF23 to trigger a deterioration spiral leading to progressive nephron loss. In humans, the progression of chronic kidney disease (CKD) ensued when serum FGF23 levels exceeded 53 pg/mL. The present study identified calcium phosphate particles in the renal tubular fluid as an effective therapeutic target to decelerate nephron loss during the course of aging and CKD progression.

Authors

Kazuhiro Shiizaki, Asako Tsubouchi, Yutaka Miura, Kinya Seo, Takahiro Kuchimaru, Hirosaka Hayashi, Yoshitaka Iwazu, Marina Miura, Batpurev Battulga, Nobuhiko Ohno, Toru Hara, Rina Kunishige, Mamiko Masutani, Keita Negishi, Kazuomi Kario, Kazuhiko Kotani, Toshiyuki Yamada, Daisuke Nagata, Issei Komuro, Hiroshi Itoh, Hiroshi Kurosu, Masayuki Murata, Makoto Kuro-o

×

Figure 1

Calcium phosphate particles induce renal tubular cell damage.

Options: View larger image (or click on image) Download as PowerPoint
Calcium phosphate particles induce renal tubular cell damage.
(A) Human ...
(A) Human HK-2 renal proximal tubule cells were cultured in control medium (DMEM containing 0.1% FBS, 3 mM calcium, and 1 mM phosphate) or in high-phosphate media (DMEM containing 0.1% FBS, 3 mM calcium, and 3, 5, or 7 mM phosphate). Cell viability was quantified 24 hours later by MTT assay and is expressed as the percentage of viable cells in the control medium. The same experiment was repeated in the presence of alendronate at the indicated concentrations. Data represent the mean ± SD. n = 4 for each culture condition. **P < 0.0001 versus the control in each culture condition, by 1-way ANOVA with Tukey’s multiple-comparison test. (B) Transmission electron microscopic observation of the medium containing 7 mM phosphate. Scale bar: 500 nm. (C) Particle size distribution of calcium phosphate particles. DMEM containing 3 mM calcium and 7 mM phosphate was incubated at room temperature for 24 hours and then subjected to nanoparticle tracking analysis before (black, CaPi particles) or after centrifugation at 16,000g for 30 minutes (CFG) or treatment with HCl (at 100 mM for 30 minutes) or EDTA (at 50 mM for 30 minutes). (D) The relative viability of HK-2 cells cultured in the control medium and in the supernatant (sup) of the high-phosphate medium (7 mM phosphate) after centrifugation at 16,000g for 2 hours was determined by MTT assay. Data represent the mean ± SD. n = 9 for each culture condition. No significant difference was observed (NS) by Student’s t test. (E) Relative viability of HK-2 cells cultured in the control medium inoculated with the indicated doses of synthesized calcium phosphate particles. Data represent the mean ± SD. n = 8 for each culture condition. *P < 0.05 and **P < 0.0001 versus control, by 1-way ANOVA with Dunnett’s multiple-comparison test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts